CHINA STATE CON(03311)2022-04-21 04:01Financial Performance - The group's unaudited revenue for the three months ended March 31, 2022, was approximately HKD 17,325,929,000, compared to HKD 13,959,135,000 for the same period in 2021, representing a year-on-year increase of about 24.4%[4] - The unaudited operating profit for the same period was approximately HKD 2,904,704,000, up from HKD 2,406,654,000 in 2021, indicating a growth of around 20.7%[4] - The group reported a significant increase in both revenue and operating profit, reflecting strong operational performance in the first quarter of 2022[4][5] Contracts and Projects - The total new contracts signed by the group for the three months ended March 31, 2022, amounted to approximately HKD 45.01 billion[5] - As of March 31, 2022, the group's uncompleted contract amount was approximately HKD 285.68 billion[5] - Major new contracts included the Tseung Kwan O Chinese Medicine Hospital project with a contract value of approximately HKD 8.11 billion[6] - The group also secured a contract for the relocation housing project in Chuzhou, Anhui, valued at approximately HKD 1.51 billion[6] - The contract for the design and construction of the People's Hospital in Foshan, Guangdong, was approximately HKD 1.96 billion[6] Financial Data Disclaimer - The financial data provided is unaudited and should be considered for reference only, as it may differ from the audited financial statements[7] - The company emphasizes the importance of consulting professional advisors for any investment decisions based on this data[8]